CTOs on the Move

eCardio Diagnostics

www.ecardio.com

 
With deep roots in ambulatory monitoring technology, eCardio Diagnostics was formed to simplify and streamline the processes of cardiac event monitoring.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.ecardio.com
  • 1442 Lake Front Cir
    Spring, TX USA 77380
  • Phone: 281.465.5200

Executives

Name Title Contact Details

Similar Companies

Esprit Home Care

Esprit Home Care is a Leesburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RF Technologies

RF Technologies is a leading provider of safety and security solutions for the healthcare, hospitality, and education markets, leveraging radio frequency identification (RFID) and PinPoint® real-time locating system (RTLS) technologies.

Medtech Surgical Inc

Medtech Surgical Inc is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ats Medical Services Inc

Ats Medical Services Inc is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.